StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) KPIs and segments

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Perspective Therapeutics's business

Perspective Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Perspective Therapeutics's fiscal year ends December 31 — Q4 2022 = CQ2 2022 (calendar quarter).

Periods
Add to chartMetric
Q4 2022
Q3 2022
Brachytherapy Segment($M)
2.512.91
Drug Operations Segment($M)
00
Drug Operations Segment($M)
00
Brachytherapy Segment($M)
-0.79-0.06
Brachytherapy Segment($M)
0.931.44
Drug Operations Segment($M)
00

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2023-08-11.

See a number that looks wrong?